CM Life Sciences III Inc. (CMLTU) News
Filter CMLTU News Items
CMLTU News Results
|Loading, please wait...|
Latest CMLTU News From Around the Web
Below are the latest news stories about CM Life Sciences III Inc that investors may wish to consider to help them evaluate CMLTU as an investment opportunity.
CM Life Sciences III Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Closing of $552 Million Initial Public Offering
CM Life Sciences III Inc. (the "Company") announced today that it closed its initial public offering of 55,200,000 units at $10.00 per unit, including 7,200,000 units issued pursuant to the exercise in full by the underwriters of its over-allotment option. The units are listed on The Nasdaq Capital Market ("Nasdaq") and began trading under the ticker symbol "CMLTU" on April 7, 2021. Each unit consists of one share of Class A common stock and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols "CMLT" and "CMLTW," respectively.